CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current assets
Cash	$ 9,854,816	$ 13,858,798
Prepaid drug product for testing	404,378	154,667
Other current assets	200,773	100,494
Total current assets	10,459,967	14,113,959
Fixed assets
Furniture, fixtures & equipment	123,410	123,410
Less Accumulated Depreciation	(41,137)	(10,284)
Property, Plant and Equipment, Net	82,273	113,126
Other assets
Technology licenses	2,500,374	2,500,374
Less Accumulated Amortization	(1,369,949)	(1,249,481)
Intangible Assets, Net (Excluding Goodwill), Total	1,130,425	1,250,893
TOTAL ASSETS	11,672,665	15,477,978
Current liabilities
Accounts payable	127,120	41,026
Accounts payable - related party	0	100,450
Accrued expense	354,109	253,445
Accrued expense - related party	0	67,050
Accrued license payments - related party	0	100,000
Total current liabilities	481,229	561,971
Long term debt	0	0
TOTAL LIABILITIES	481,229	561,971
Shareholders' Equity
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	0	0
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 9/30/15 and 12/31/14, respectively	89,763	89,763
Additional paid in capital	35,026,695	34,743,489
Accumulated deficit	(23,925,022)	(19,917,245)
Total shareholders' equity	11,191,436	14,916,007
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	$ 11,672,665	$ 15,477,978